We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEPAW
13276
DELISTED
SEP Acquisition Corp Warrants
SEPAW
$5.73K ﹤0.01%
60,746
+29,549
+95% +$1.94K
ATER icon
13277
PUT
Aterian
ATER
$5.44M
$5.72K ﹤0.01%
1,458
-342
-19% -$1.77K
IMMR icon
13278
Immersion
IMMR
$249M
$5.71K ﹤0.01%
864
+240
+38% +$1.67K
EMX
13279
PUT
DELISTED
EMX Royalty
EMX
$5.7K ﹤0.01%
3,200
+3,000
+1,500% +$5.5K
CCO icon
13280
PUT
Clear Channel Outdoor Holdings
CCO
$1.19B
$5.69K ﹤0.01%
3,600
-500
-12% -$758
ELA icon
13281
PUT
Envela
ELA
$416M
$5.69K ﹤0.01%
1,200
-4,700
-80% -$28.4K
DISTR
13282
DELISTED
Distoken Acquisition Corporation Right
DISTR
$5.66K ﹤0.01%
29,772
+5,019
+20% +$984
TCBP
13283
DELISTED
TC BioPharm (Holdings) plc American Depositary Shares
TCBP
$5.65K ﹤0.01%
4
-20
-83% -$33K
VEL icon
13284
CALL
Velocity Financial
VEL
$717M
$5.65K ﹤0.01%
+500
New +$6.08K
AMPGW
13285
DELISTED
Amplitech Group Warrants
AMPGW
$5.6K ﹤0.01%
32,940
+9,005
+38% +$3.11K
LUCYW icon
13286
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$78.6K
$5.58K ﹤0.01%
+39,223
New +$5.85K
CMRA
13287
DELISTED
Comera Life Sciences Holdings, Inc. Common Stock
CMRA
$5.57K ﹤0.01%
+17,458
New +$9.21K
AIA icon
13288
PUT
iShares Asia 50 ETF
AIA
$5.06B
$5.54K ﹤0.01%
100
-3,800
-97% -$224K
MCAGR
13289
DELISTED
Mountain Crest Acquisition Corp. V Right
MCAGR
$5.54K ﹤0.01%
+27,589
New +$4.52K
KRNY icon
13290
PUT
Kearny Financial
KRNY
$605M
$5.54K ﹤0.01%
800
+500
+167% +$3.79K
SJB icon
13291
PUT
ProShares Short High Yield
SJB
$47.6M
$5.54K ﹤0.01%
300
-700
-70% -$12.8K
STIM icon
13292
PUT
Neuronetics
STIM
$230M
$5.54K ﹤0.01%
4,100
+200
+5% +$350
ATYR
13293
PUT
aTyr Pharma
ATYR
$54.8M
$5.53K ﹤0.01%
3,500
-10,000
-74% -$18.5K
EGAN icon
13294
PUT
eGain
EGAN
$206M
$5.52K ﹤0.01%
900
+500
+125% +$3.37K
GANX icon
13295
CALL
Gain Therapeutics
GANX
$90.4M
$5.49K ﹤0.01%
1,700
-15,200
-90% -$57.6K
RSVR
13296
CALL
Reservoir Media
RSVR
$657M
$5.49K ﹤0.01%
900
-1,100
-55% -$6.17K
BMRC icon
13297
CALL
Bank of Marin Bancorp
BMRC
$458M
$5.48K ﹤0.01%
300
+100
+50% +$1.93K
EVC icon
13298
PUT
Entravision Communication
EVC
$832M
$5.47K ﹤0.01%
+1,500
New +$6.11K
KYNB
13299
PUT
Kyntra Bio
KYNB
$28.5M
$5.44K ﹤0.01%
252
-15,240
-98% -$598K
PEB icon
13300
PUT
Pebblebrook Hotel Trust
PEB
$2.06B
$5.44K ﹤0.01%
400
-136,700
-100% -$1.96M

Similar funds

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.